Overview

Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effect of multiple doses of secretin on autism.
Phase:
Phase 3
Details
Lead Sponsor:
Repligen Corporation
Treatments:
Secretin